company background image
BKL

Blackmores ASX:BKL Stock Report

Last Price

AU$63.63

Market Cap

AU$1.2b

7D

-0.9%

1Y

-32.7%

Updated

04 Oct, 2022

Data

Company Financials +
BKL fundamental analysis
Snowflake Score
Valuation2/6
Future Growth4/6
Past Performance4/6
Financial Health6/6
Dividends0/6

BKL Stock Overview

Blackmores Limited develops, sells, and markets natural health products for humans and animals in Australia, New Zealand, Asia, China, and India.

Blackmores Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Blackmores
Historical stock prices
Current Share PriceAU$63.63
52 Week HighAU$103.97
52 Week LowAU$62.23
Beta0.44
1 Month Change-6.08%
3 Month Change-14.04%
1 Year Change-32.74%
3 Year Change-22.36%
5 Year Change-48.41%
Change since IPO2,213.82%

Recent News & Updates

Shareholder Returns

BKLAU Personal ProductsAU Market
7D-0.9%-0.9%-0.7%
1Y-32.7%-49.3%-11.7%

Return vs Industry: BKL exceeded the Australian Personal Products industry which returned -49.3% over the past year.

Return vs Market: BKL underperformed the Australian Market which returned -11.7% over the past year.

Price Volatility

Is BKL's price volatile compared to industry and market?
BKL volatility
BKL Average Weekly Movement5.1%
Personal Products Industry Average Movement10.2%
Market Average Movement9.4%
10% most volatile stocks in AU Market16.5%
10% least volatile stocks in AU Market4.2%

Stable Share Price: BKL is less volatile than 75% of Australian stocks over the past 3 months, typically moving +/- 5% a week.

Volatility Over Time: BKL's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19301,200Alastair Symingtonhttps://www.blackmores.com.au

Blackmores Limited develops, sells, and markets natural health products for humans and animals in Australia, New Zealand, Asia, China, and India. The company offers vitamins, and herbal and mineral nutritional supplements. It also provides products for various conditions related to arthritis, joints, bones, and muscles; brain health; cold, flu, and immunity; digestive health; energy and exercise; everyday health; and eye health.

Blackmores Limited Fundamentals Summary

How do Blackmores's earnings and revenue compare to its market cap?
BKL fundamental statistics
Market CapAU$1.24b
Earnings (TTM)AU$30.62m
Revenue (TTM)AU$651.06m

40.4x

P/E Ratio

1.9x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
BKL income statement (TTM)
RevenueAU$651.06m
Cost of RevenueAU$247.71m
Gross ProfitAU$403.35m
Other ExpensesAU$372.73m
EarningsAU$30.62m

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)1.57
Gross Margin61.95%
Net Profit Margin4.70%
Debt/Equity Ratio0%

How did BKL perform over the long term?

See historical performance and comparison

Dividends

1.5%

Current Dividend Yield

60%

Payout Ratio